Inspire Medical Systems, Inc.
INSP· NYSE
INSPInspire Medical Systems, Inc.
Filed Feb 10, 2023 · 10-K · 41 days after period end · 0001609550-23-000024
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $137.90M | $78.40M | $46.01M | $26.91M |
| Net Income | $3.15M | -$2.39M | -$7.48M | -$9.08M |
| EPS Diluted | — | — | -$0.28 | -$0.38 |
Inspire Medical Systems, Inc. · CIK 1609550 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Feb 10, 2023 · 41 d after period end
